FDA 510(k) FDA class 2 Substantially Equivalent 🇺🇸 United States

Tina-quant Hemoglobin A1cDx Gen.3

K Number: K193053 · Decision Mar 26, 2020
Classifications
1
FEI Numbers
34
Registration Numbers
34
Same Product Code
25
Applicant Total
14
Review Days
146

Research this 510(k) in seconds

The Research Assistant summarizes clearance history, predicates and product-code trends — and cites every record.

Free to try · every answer cites its records

Basic Information

Device Name
Tina-quant Hemoglobin A1cDx Gen.3
K Number
K193053
Device Class
FDA class 2
Clearance Type
Traditional
Regulation Number
862.1373
Medical Specialty
Clinical Chemistry
Decision
Substantially Equivalent
Statement or Summary
Summary
Applicant
Roche Diagnostics Operations (Rdo)
Date Received
November 1, 2019
Decision Date
March 26, 2020
Product Code
PDJ
Advisory Committee
Clinical Chemistry
Review Advisory Committee
CH
Third Party
N

Classifications

This FDA 510(k) entry is associated with 1 FDA classification via its product code.

Product Code Device Name
PDJ Hemoglobin A1c Test System

Similar 510(k) Clearances

Other 510(k) clearances with the same product code (PDJ), ordered by most recent decision date.

View all

Other Clearances by Roche Diagnostics Operations (Rdo)

K Number Device Name
K192072 Tina-quant C-Reactive Protein IV
K183517 Ammonia II
K182095 Tina-quant Transferrin ver.2 (urine application)
K171080 ALP IFCC Gen.2
K160571 cobas c513 Analyzer, cobas c13 Tina-quant HbA1cDx Gen.3 Assay
K162593 HDL-Cholesterol Gen.4
K161817 Tina-quant Cystatin C Gen.2
K160570 Creatine Kinase
K152245 ONLINE TDM Vancomycin Gen.3
K151578 Carbamazepine Gen 4
Search all 14 clearances from Roche Diagnostics Operations (Rdo) →